Skip to content

Retraining Attention to Treat Alcohol Dependence and Social Anxiety

Cognitive Bias Modification: A Novel Intervention for Alcohol Dependence and Social Anxiety

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01886716
Acronym
AMP
Enrollment
115
Registered
2013-06-26
Start date
2013-07-31
Completion date
2014-12-31
Last updated
2016-12-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol Drinking, Anxiety Disorders

Keywords

Alcohol Abuse, Alcohol Dependence, Alcohol Drinking, Social Anxiety, Social Phobia, Anxiety Disorders

Brief summary

The purpose of this research is to test a computerized intervention for people with co-occurring social anxiety and alcohol dependence. The intervention seeks to reduce symptoms by shifting attention away from alcohol-relevant and/or socially threatening cues. The investigators expect that participants receiving alcohol or anxiety training will experience reductions in those specific symptoms compared to participants in a control condition. The investigators also expect that participants receiving combined alcohol and anxiety training will show the largest reductions in alcohol and anxiety symptoms, relative to participants in any other condition.

Detailed description

Alcohol Use Disorders (AUDs) and Social Anxiety Disorder are disabling and chronic conditions. In spite of these common and significantly overlapping problems, insight into the mechanisms linking alcohol dependence and social anxiety symptoms is minimal, and there are not well established treatment guidelines for this population. In this study, the investigators seek to develop a computerized intervention for individuals with symptoms of social anxiety and alcohol dependence. The intervention attempts to reduce symptoms by shifting attention away from alcohol-relevant and/or socially threatening cues. The investigators expect that participants receiving alcohol or anxiety training will experience reductions in those specific symptoms compared to participants in a control condition. The investigators also expect that participants receiving combined alcohol and anxiety training will show the largest reductions in alcohol and anxiety symptoms, relative to participants in any other condition.

Interventions

BEHAVIORALAnxiety Attention Training

Anxiety Attention Training will preferentially direct participants' attention away from reminders of anxiety.

BEHAVIORALAlcohol Attention Training

Alcohol Attention Training will preferentially direct participants' attention away from reminders of alcohol.

Placebo Anxiety Training and Placebo Alcohol Training will not preferentially direct participants' attention away from reminders of anxiety or alcohol.

Sponsors

Miami University
CollaboratorOTHER
Brown University
CollaboratorOTHER
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
CollaboratorNIH
University of Cincinnati
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Current alcohol dependence * Elevated social anxiety symptoms * Willingness to consider cutting down on drinking

Exclusion criteria

* Current psychosis * Unmanaged manic symptoms * Significant cognitive impairment * Other drug use in past month * Receiving cognitive behavioral therapy for alcohol use disorder or social anxiety * Unable to read

Design outcomes

Primary

MeasureTime frameDescription
Liebowitz Social Anxiety ScaleBaseline, weekly throughout the 4-week trial, and in the follow-up sessions (1 week and 1 month follow-ups)The experimenter-administered Liebowitz Social Anxiety Scale (Liebowitz, 1987) was the primary measure to assess social anxiety symptoms. This well-validated instrument assesses fear and avoidance across a range of 24 social and performance situations during the course of the previous week. A total LSAS score was computed, ranging from 0 (no fear or avoidance) to 144 (the greatest level of fear and avoidance).
The Daily Drinking QuestionnaireBaseline, weekly throughout the 4-week trial, and in the follow-up sessions (1 week and 1 month follow-ups)The Daily Drinking Questionnaire (Collins, Parks, & Marlatt, 1985) was the primary measure used to assess weekly alcohol consumption. This calendar-based measure was administered by the experimenter once per week to monitor changes in symptoms. The measure assessed the total number of drinks in the past week.

Countries

United States

Participant flow

Pre-assignment details

Random assignment occurred during Week 1, the next visit after the baseline orientation session. Out of 115 participants completing the baseline session, 21 dropped out prior to random assignment. To ensure current symptoms, another 8 were excluded due to baseline reports of no or extremely low alcohol consumption and/or social anxiety, leaving 86.

Participants by arm

ArmCount
Anxiety Attention Training Only
Participants will receive Anxiety Attention Training and placebo Alcohol training. Anxiety Attention Training: Anxiety Attention Training will preferentially direct participants' attention away from reminders of anxiety.
24
Alcohol Attention Training Only
Participants will receive Alcohol Attention Training and placebo Anxiety training. Alcohol Attention Training: Alcohol Attention Training will preferentially direct participants' attention away from reminders of alcohol.
20
Anxiety + Alcohol Attention Training
Participants will receive both Anxiety Attention Training and Alcohol Attention Training. Anxiety Attention Training: Anxiety Attention Training will preferentially direct participants' attention away from reminders of anxiety. Alcohol Attention Training: Alcohol Attention Training will preferentially direct participants' attention away from reminders of alcohol.
22
Control Training
Participants will receive placebo Anxiety Training and placebo Alcohol training. Control Training: Placebo Anxiety Training and Placebo Alcohol Training will not preferentially direct participants' attention away from reminders of anxiety or alcohol.
20
Total86

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003
Week 1Lost to Follow-up0022
Week 2Lost to Follow-up3213
Week 3Lost to Follow-up1101

Baseline characteristics

CharacteristicAlcohol Attention Training OnlyAnxiety + Alcohol Attention TrainingAnxiety Attention Training OnlyControl TrainingTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
1 Participants1 Participants0 Participants0 Participants2 Participants
Age, Categorical
Between 18 and 65 years
19 Participants21 Participants24 Participants20 Participants84 Participants
Age, Continuous47.40 years
STANDARD_DEVIATION 10.94
47.68 years
STANDARD_DEVIATION 9.83
42.50 years
STANDARD_DEVIATION 10.95
39.70 years
STANDARD_DEVIATION 10.62
44.31 years
STANDARD_DEVIATION 10.93
Gender
Female
9 Participants7 Participants9 Participants10 Participants35 Participants
Gender
Male
11 Participants15 Participants15 Participants10 Participants51 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants1 Participants0 Participants0 Participants1 Participants
Race (NIH/OMB)
Asian
1 Participants0 Participants0 Participants0 Participants1 Participants
Race (NIH/OMB)
Black or African American
10 Participants11 Participants14 Participants10 Participants45 Participants
Race (NIH/OMB)
More than one race
0 Participants1 Participants0 Participants4 Participants5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
9 Participants9 Participants10 Participants6 Participants34 Participants
Region of Enrollment
United States
20 participants22 participants24 participants20 participants86 participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —— / —
other
Total, other adverse events
0 / 240 / 200 / 220 / 20
serious
Total, serious adverse events
0 / 240 / 200 / 220 / 20

Outcome results

Primary

Liebowitz Social Anxiety Scale

The experimenter-administered Liebowitz Social Anxiety Scale (Liebowitz, 1987) was the primary measure to assess social anxiety symptoms. This well-validated instrument assesses fear and avoidance across a range of 24 social and performance situations during the course of the previous week. A total LSAS score was computed, ranging from 0 (no fear or avoidance) to 144 (the greatest level of fear and avoidance).

Time frame: Baseline, weekly throughout the 4-week trial, and in the follow-up sessions (1 week and 1 month follow-ups)

ArmMeasureValue (MEAN)Dispersion
Anxiety Attention Training OnlyLiebowitz Social Anxiety Scale56.80 units on a scaleStandard Deviation 30.82
Alcohol Attention Training OnlyLiebowitz Social Anxiety Scale60.94 units on a scaleStandard Deviation 27.7
Anxiety + Alcohol Attention TrainingLiebowitz Social Anxiety Scale52.05 units on a scaleStandard Deviation 27.23
Control TrainingLiebowitz Social Anxiety Scale55.05 units on a scaleStandard Deviation 26.08
Comparison: The analyses used multilevel modeling to capture both the trajectories of symptoms within individuals (i.e., level 1) and the hypothesized between-subject moderators of these trajectories, alcohol and anxiety attention training (i.e., level 2) across all 7 time points.~Note, although all 4 groups are included in this analysis, this analysis specifically compares anxiety vs. control training.p-value: =0.4Mixed Models Analysis
Comparison: The analyses used multilevel modeling to capture both the trajectories of symptoms within individuals (i.e., level 1) and the hypothesized between-subject moderators of these trajectories, alcohol and anxiety attention training (i.e., level 2) across all 7 time points.~Note, although all 4 groups are included in this analysis, this analysis specifically compares alcohol vs. control training.p-value: =0.78Mixed Models Analysis
Primary

The Daily Drinking Questionnaire

The Daily Drinking Questionnaire (Collins, Parks, & Marlatt, 1985) was the primary measure used to assess weekly alcohol consumption. This calendar-based measure was administered by the experimenter once per week to monitor changes in symptoms. The measure assessed the total number of drinks in the past week.

Time frame: Baseline, weekly throughout the 4-week trial, and in the follow-up sessions (1 week and 1 month follow-ups)

ArmMeasureValue (MEAN)Dispersion
Anxiety Attention Training OnlyThe Daily Drinking Questionnaire30.25 number of drinksStandard Deviation 39.49
Alcohol Attention Training OnlyThe Daily Drinking Questionnaire22.82 number of drinksStandard Deviation 23.03
Anxiety + Alcohol Attention TrainingThe Daily Drinking Questionnaire24.65 number of drinksStandard Deviation 24.93
Control TrainingThe Daily Drinking Questionnaire18.48 number of drinksStandard Deviation 24.09
Comparison: The analyses used multilevel modeling to capture both the trajectories of symptoms within individuals (i.e., level 1) and the hypothesized between-subject moderators of these trajectories, alcohol and anxiety attention training (i.e., level 2) across all 7 time points.~Note, although all 4 groups are included in this analysis, this analysis specifically compares alcohol vs. control trainingp-value: =0.67Mixed Models Analysis
Comparison: The analyses used multilevel modeling to capture both the trajectories of symptoms within individuals (i.e., level 1) and the hypothesized between-subject moderators of these trajectories, alcohol and anxiety attention training (i.e., level 2) across all 7 time points.~Note, although all 4 groups are included in this analysis, this analysis specifically compares anxiety vs. control trainingp-value: =0.32Mixed Models Analysis

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026